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http:WHAT THIS PAPER ADDS
Type II endoleak (EL II) is a recurrent problem after endovascular aneurysm repair. Although most EL II are
benign, some lead to aneurysm sac enlargement with a risk of rupture. Endovascular embolization techniques
are classically used to treat EL II, but the results are not always convincing. Conversion to open repair with stent
graft (SG) explantation, used as a rescue procedure, is often associated with high peri-operative morbidity and
mortality. Herein, an alternative option is proposed for EL II repair, combining sacotomy with ligation of the
patent back bleeding vessels and preservation of the SG. This option is particularly useful after failure of
embolization in frail patients.Objective/Background: Persistent type II endoleak (EL II) with sac enlargement after endovascular repair of
abdominal aortic aneurysm requires treatment to prevent rupture. Embolization is not always effective.
Conversion to open repair with stent graft (SG) explantation is a high risk option. The aim of this study was to
evaluate the feasibility and immediate results of an alternative technique combining obliterative
endoaneurysmorrhaphy (OEA) with SG preservation.
Methods: The open surgical technique combined sacotomy, ligation of all patent back-bleeding vessels and SG
preservation. The aneurysmal shell was tightly closed over the SG to protect it from the intestines. An intra-aortic
occlusion balloon was used when clamping was required.
Results: Twelve patients were treated with the OEA technique at Amiens University Hospital. All 12 procedures
were successful. Four patients had previously undergone unsuccessful transarterial or translumbar embolization.
Aortic clamping was performed in four cases. No SG migration or graft dislocation was observed. Follow up
computed tomography scan at a median of 12 months showed shrinkage of the aneurysm sac with stable
diameters and no recurrence of EL II in all cases.
Conclusion: The OEA technique is an alternative option for the treatment of progressive EL II, which can be
particularly useful after failure of embolization.
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Article history: Received 29 December 2014, Accepted 8 July 2015, Available online 18 August 2015
Keywords: Endoaneurysmorrhaphy, EVAR, Sac enlargement, Stent graft explantation, Type 2 endoleakINTRODUCTION
Type II endoleak (EL II) is a recurrent problem after endo-
vascular repair (EVAR) of abdominal aortic aneurysm (AAA).
Although most EL II are benign,1 some lead to aneurysm sac
enlargement with a risk of rupture.2 Endovascular emboli-
zation techniques are classically used to treat EL II, but the
results are not always successful.3 Laparoscopic repair is
technically challenging, even for experienced surgeons,
because of the dense periaortic inﬂammation after EVAR.4responding author.
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//dx.doi.org/10.1016/j.ejvs.2015.07.013Conversion to open repair with stent graft (SG) explanta-
tion, used as a rescue procedure, is a challenging procedure,
often associated with signiﬁcant peri-operative morbidity
and mortality.5 Herein, an alternative open option for EL II
repair, combining sacotomy with ligation of the patent back
bleeding vessels and preservation of the SG, is described.
MATERIALS AND METHODS
Indication
Obliterative endoaneurysmorrhaphy (OEA) with SG preser-
vation is performed, at Amiens University Hospital, to treat
EL II associated with aneurysm enlargement in three main
situations: (i) after failure of embolization techniques; (ii) in
the presence of complex EL II involving several collateral
vessels; and (iii) when the endoleak origin remains unclear
on imaging.
Obliterative Endoaneurysmorrhaphy with Stent Graft Preservation 39Culprit collaterals and SG position in the aneurysm sac
were studied pre-operatively on 1 mm computed tomog-
raphy (CT) with contrast enhancement.
Surgical details
The ﬁrst step of the procedure consists of endovascular
control of the supraceliac aorta. A 6-F introducer is placed
in a femoral artery after percutaneous puncture via a
retrograde approach or after surgical exposure. A 0.03500
hydrophilic guide wire (Terumo Europe, Leuven, Belgium) is
advanced into the SG and thoracic aorta under ﬂuoroscopic
guidance. The OEA procedure is then performed. A trans- or
retro-peritoneal approach is used, depending on the
aneurysm morphology and the surgeon’s usual practice.
Cautious dissection of the dense inﬂammatory tissue sur-
rounding the abdominal aorta is then performed. The
aneurysm sac is opened very slowly to avoid damaging the
SG and to evaluate bleeding from the sac. In the absence of
major bleeding, the thrombus is removed to identify back
bleeding vessels that are then ligated under direct vision
using 2/0 polypropylene suture material (Prolene; Ethicon,
Brussels, Belgium).
When clamping is required, a straight catheter is used to
replace the guidewire with a stiff Lunderquist guidewireFigure 1. After placing a stiff Lunderquist guide wire in the thoracic aort
artery and advanced into (B) the stent graft. (C) The balloon is ﬁnally p
suprarenal stent (lower arrow).
Figure 2. (A) Intra-operative view showing major lumbar back bleeding
elimination of type III or IV endoleak.(Cook Medical, Bloomington, IN, USA) and the 6-F intro-
ducer is replaced by a 12-F/40 cm introducer. An intra-aortic
occlusion balloon (Coda; Cook Medical) is inserted,
advanced, and placed in the supraceliac aorta above the
suprarenal stent (Fig. 1).
In the case of a fenestrated SG, the aortic occlusion
balloon is placed in the thoracic aorta via a left axillary
approach when possible, to avoid catheters crossing the
arch vessel origins.
In the presence of major lumbar bleeding, the intra-aortic
occlusion balloon is inﬂated to provide temporary hemo-
stasis. It is sometimes necessary to mobilize iliac limbs
cautiously in order to reach the lumbar or median sacral
ostia. After careful examination to rule out type III or IV
endoleak, the SG is ﬁnally left in place (Fig. 2).
The aneurysm shell is then partly resected and tightly
closed over the SG to decrease sac diameter and dead
space, using 2/0 polypropylene running sutures. Wrapping
of the aneurysm shell around the SG also allows separation
of the SG from the intestines.
Endovascular material is removed at the end of the pro-
cedure and the femoral artery is surgically sutured when
exposed or closed percutaneously with the Perclose Proglide
(Abbott Vascular, Santa Clara, CA, USA) suture mediateda, an aortic occlusion balloon (arrow) is inserted via (A) the femoral
ositioned in the low thoracic aorta (upper arrow), above the bare
after sac opening (arrow). (B) Preservation of the stent graft after
40 P. Maitrias et al.closure system. The puncture site is closed with the Femo-
seal closure device (St. Jude Medical, St. Paul, MN, USA)
when an aortic balloon is not used.Data analysis
The study was conducted in accordance with the Declara-
tion of Helsinki. The French ethics committee approved the
protocols. Data were collected prospectively. Written
informed consent for the procedure was obtained from
each patient. Results for continuous variables are expressed
as mean  SD or median  interquartile range. Categorical
variables are expressed in percentages.RESULTS
From January 2007 to December 2014 a total of 278 pa-
tients underwent an EVAR procedure at Amiens University
Centre. Twelve patients with sac enlargement were suc-
cessfully treated with the OEA technique. The median age
of the patients was 77 years (range 60e88 years) and the
median American Society of Anesthesiologists’ score was 3.
Patients’ baseline characteristics are detailed in Table 1.
A bifurcated SG with suprarenal ﬁxation was implanted in
six patients, a bifurcated SG without suprarenal ﬁxation was
implanted in two patients, and a fenestrated SG was
implanted in one patient. An aorto-uni-iliac SG with supra-
renal ﬁxation was deployed as an emergency for rupturedTable 1. Characteristics of the study population.
Baseline characteristics Number of patients (%)
Male sex 12 (100)
Hypertension 7 (58)
History of smoking 6 (50)
Diabetes mellitus 2 (17)
Ischemic heart disease 2 (17)
Congestive heart failure 1 (8)
Cardiac arrhythmias 5 (42)
Stroke 3 (25)
Renal dysfunction 1 (8)
Chronic obstructive pulmonary disease 2 (17)
Table 2. Evolution of diameter during follow up after endovascular an
Patient EVAR diameter (mm) OEA diameter, m
1 60 80 (þ20)
2 55 80 (þ25)
3 80 120 (þ40)
4 55 67 (þ12)
5 60 85 (þ25)
6 100 130 (þ30)
7 100 105 (þ5)
8 100 105 (þ5)
9 54 71 (þ17)
10 60 72 (þ12)
11 80 90 (þ10)
12 80 88 (þ8)
Mean/mediana 70 (54e100) 86 (67e130)
Note. OEA ¼ obliterative endoaneurysmorrhaphy.
a Mean  SD; median (range).aneurysm in three patients. All patients had regular follow
up after EVAR, with an annual CT scan.
During follow up, transarterial embolization was per-
formed in four patients with sac enlargement related to
clearly identiﬁed EL II (two coil embolizations of a patent
inferior mesenteric artery and two coil embolizations of
patent lumbar arteries). None of these procedures eradi-
cated the leak or stopped sac expansion. Translumbar
embolization was performed in one patient after failure
of repeated unsuccessful transarterial embolization. The
OEA procedure was then performed after failure of
embolization.
Two patients with endoleak of undetermined origin on
imaging examinations and four patients with complex EL II
with multiple origins were treated directly by OEA.
Two patients presented sac enlargement with no visible
endoleak on CT scan.
Median aneurysmal diameter was 70 mm (range 54e
100mm) at the time of EVAR and 86mm (range 67e130mm)
at the time of OEA representing a 25% mean increase in
diameter, with a mean follow up of 20 months between the
two procedures (Table 2).
Surgical access was obtained in 10 cases via a midline
transperitoneal approach and in two cases via a left retro-
peritoneal incision. Clamping with intra-aortic occlusion
balloon was performed in four cases (to eliminate occult
proximal type I endoleak or to reduce lumbar bleeding).
Mean aortic occlusion time was 7  4 minutes. No type I
endoleak was identiﬁed intra-operatively. EL II were iden-
tiﬁed in 10 patients, mostly involving lumbar, inferior
mesenteric, and median sacral vessels. One to six vessels
were ligated (Table 3). One patient presented with EL II
associated with a type III endoleak, which was treated by
endovascular SG reinforcement. One patient presented true
endotension without retrograde perfusion of the sac,
treated by tight closure of the aneurysm shell over the SG.
No SG plication, disjunction, or migration was observed
during the procedures.
Mean operating time was 120  35 minutes and mean
blood loss was 505  385 mL.eurysm repair (EVAR).
m (increase) Diameter increase (%) Length (mo)
33 36
45 11
50 49
22 44
42 8
30 30
5 8
5 8
31 17
20 12
13 10
10 12
25  13 20  13
Table 3. Details of intra-operative data.
Patient Pre-operative imaging data Intra-operative diagnosis Number and type of ligated vessels Associated procedure
1 EL undetermined EL II 2 (L) d
2 EL II (L, IM) EL II 4 (L, IM, MS) d
3 EL undetermined EL II 2 (L) d
4 EL II (L, IM) EL II 3 (L, IM, MS) d
5 No visible leak EL II 1 (IM) d
6 No visible leak Endotension 0 d
7 EL II (L) EL II 5 (L, IM) d
8 EL II (IM) EL II 3 (L, IM) d
9 EL II (L, IM) EL II 5 (L, IM, MS) d
10 EL II (L, IM, MS) EL II 6 (L, IM, MS) d
11 EL II (L, IM) EL II þ type III 2 (L, IM) SG reinforcement
12 EL II (L) EL II 2 (L) d
Note. EL ¼ endoleak; EL II ¼ endoleak type II; L ¼ lumbar; IM ¼ inferior mesenteric; MS ¼ median sacral; SG ¼ stent graft.
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complications occurred in two patients (pneumonia and
heart failure), resolving in response to medical treatment.
Median hospital stay was 8 days (range 5e15 days).
With a median follow up of 12 months (range 6e39
months), control CT scan showed shrinkage of the aneurysm
sac with stable diameters in every case. No missed EL II, no
recurrence, and no SG migration or dislocation were
observed (Fig. 3).DISCUSSION
In the experience of the authors, OEA with SG preservation
for the treatment of progressive EL II was always feasible
with excellent immediate results.
EL II is an ongoing problem after EVAR. Although EL II are
present in nearly 15% of cases during the early post-
operative period, up to 40% closing spontaneously during
the ﬁrst year of follow up.1,2 While some authors have re-
ported that conservative management of EL II is a safe
option,6,7 others have shown that EL II increase the risk of
rupture.8,9 According to current guidelines, treatment is
recommended for persistent EL II associated with sac
enlargement.10
Transarterial, transcaval, and translumbar embolization
have been described for EL II repair with controversial re-
sults.3,11,12 The systematic review by Sidloff et al. showed
that translumbar embolization had a higher success rateFigure 3. (A) Axial pre-operative computed tomography scan showing
endoleak at 6 month follow up.and a lower risk of complications than transarterial embo-
lization.13 Laparoscopic repair is technically challenging
because of the dense periaortic inﬂammation after EVAR.4
Surgeons experienced in laparoscopic aortic surgery have
recently described access to the lumbar and median sacral
arteries in the plane of the anterior longitudinal ligament.14
Voûte et al. described laparoscopic clipping of side branches
and aneurysm sac fenestration with signiﬁcant rates of
conversion or additional procedures for persistent EL II.15
Open repair with SG removal is a complicated surgical
procedure associated with high morbidity and mortality
rates in frail patients.5 A few cases of sacotomy with ligation
of back bleeding vessels have been reported,16,17 but this
technique has not yet been speciﬁcally described.
Initial placement of an intra-aortic occlusion balloon al-
lows (i) a limited dissection of the abdominal aorta to be
performed, as the supraceliac aorta is not surgically cross
clamped; (ii) immediate inﬂation to clamp the aorta in the
case of an occult proximal type I endoleak; and (iii) tem-
porary hemostasis to limit blood loss in the case of major
collateral back bleeding. No case of type I endoleak was
observed in this study. When lumbar bleeding was profuse,
inﬂation of the intra-aortic occlusion balloon led to a sig-
niﬁcant decrease in ﬂow thereby limiting blood loss.
Surgical dissection of the aorta should be limited to be
just sufﬁcient to provide adequate access to the sac, close
to the origin of the patent aortic side branches detected on
pre-operative CT scan. Sacotomy allows visual identiﬁcationa large type II endoleak (arrow). (B) Sac retraction and absence of
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detected on pre-operative imaging that can then be
repaired at the same time. In this study, one patient with
visible EL II on pre-operative CT scan presented with EL II
from lumbar, inferior mesenteric, and median sacral origins,
associated with a type III endoleak not detected pre-
operatively. As shown in Table 3, the OEA procedure
allowed the diagnosis of EL II in two patients with endoleak
of undetermined origin and in one patient with no visible
leak. Endotension with no patent back bleeding vessel was
observed in one patient with no visible leak on pre-
operative CT. The lack of sensitivity of helical CT for visual-
ization of EL II has been described previously,18 but this
examination currently remains the most accessible imaging
modality for patient follow up.
During the procedure, access to either proximal lumbar
arteries in the neck or distal lumbar and median sacral ar-
teries close to the aortic bifurcation can be difﬁcult. If
necessary, the SG can be very carefully mobilized avoiding
graft damage or displacement. In the present experience, it
was always possible to ligate lumbar and median sacral
ostia from inside the aorta and the SG main body or limbs
did not have to be removed. It is important to plicate the
aneurysm sac over the SG to prevent contact and erosion of
bowel on the graft. This wrapping also avoids SG migration
or dislocation.
Few post-operative complications were observed and
were always related to comorbidities. This report is limited
by its observational design and by the small number of
patients. Although OEA with SG preservation is feasible and
gave good immediate results, more patients and a longer
follow up are required to conﬁrm this technique as a safe
and lasting treatment for progressive EL II.
CONCLUSION
This technique can be considered to be an alternative to SG
removal in the case of persistent EL II with aneurysm sac
enlargement after failed embolization. By avoiding exten-
sive dissection for surgical aortic cross clamping, minimizing
hemodynamic changes, reducing blood loss, and operating
time, this procedure can be performed even in patients
initially considered unﬁt for surgery.
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